Skip to content

Co-trimoxazole reduces risk of death for children in Zambia, should be given to all children with HIV symptoms, say researchers

Atazanavir/ritonavir shows comparable efficacy to Kaletra at 96 weeks for PI-experienced patients

Rates of TB treatment interruption unaffected by HIV infection or HAART

AZT resistance suppression mutations can also reduce tenofovir resistance, test tube study shows (corrected)

Double boosted protease inhibitors generate interest at Glasgow conference

High resistance levels seen in treated Ugandans: cost of therapy blamed

Truvada receives scientific approval in Europe

Once-daily abacavir receives approval in Europe

Infection with multi-drug resistant virus is lifelong, Canadian expert argues